These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 37899662)
1. Clinicopathological characteristics of cutaneous complications following COVID-19 vaccination: A case series. Diab R; Rakhshan A; Salarinejad S; Pourani MR; Ansar P; Abdollahimajd F J Cosmet Dermatol; 2024 Mar; 23(3):725-730. PubMed ID: 37899662 [TBL] [Abstract][Full Text] [Related]
2. Cutaneous manifestations following COVID-19 vaccination: A report of 25 cases. Shakoei S; Kalantari Y; Nasimi M; Tootoonchi N; Ansari MS; Razavi Z; Etesami I Dermatol Ther; 2022 Aug; 35(8):e15651. PubMed ID: 35716105 [TBL] [Abstract][Full Text] [Related]
3. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Seirafianpour F; Pourriyahi H; Gholizadeh Mesgarha M; Pour Mohammad A; Shaka Z; Goodarzi A Dermatol Ther; 2022 Jun; 35(6):e15461. PubMed ID: 35316551 [TBL] [Abstract][Full Text] [Related]
4. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. McMahon DE; Kovarik CL; Damsky W; Rosenbach M; Lipoff JB; Tyagi A; Chamberlin G; Fathy R; Nazarian RM; Desai SR; Lim HW; Thiers BH; Hruza GJ; French LE; Blumenthal K; Fox LP; Freeman EE J Am Acad Dermatol; 2022 Jan; 86(1):113-121. PubMed ID: 34517079 [TBL] [Abstract][Full Text] [Related]
5. Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study. Cebeci Kahraman F; Savaş Erdoğan S; Aktaş ND; Albayrak H; Türkmen D; Borlu M; Arıca DA; Demirbaş A; Akbayrak A; Polat Ekinci A; Gökçek GE; Çelik HA; Taşolar MK; An İ; Temiz SA; Hazinedar E; Ayhan E; Hızlı P; Solak EÖ; Kılıç A; Yılmaz E J Cosmet Dermatol; 2022 Sep; 21(9):3692-3703. PubMed ID: 35780311 [TBL] [Abstract][Full Text] [Related]
6. Clinical observation and analysis of skin reactions caused by COVID-19 vaccination. Li Y; Fan L; Mao Q; Luan X; Wang Z; Zeng N; Cheng Y; Li Y; Xia Q; Lu Z; Lu Q; Min W; Luo D Dermatol Ther; 2022 Oct; 35(10):e15746. PubMed ID: 36190010 [TBL] [Abstract][Full Text] [Related]
7. Adverse effects following COVID-19 vaccination in Iran. Babaee E; Amirkafi A; Tehrani-Banihashemi A; SoleimanvandiAzar N; Eshrati B; Rampisheh Z; Asadi-Aliabadi M; Nojomi M BMC Infect Dis; 2022 May; 22(1):476. PubMed ID: 35585518 [TBL] [Abstract][Full Text] [Related]
8. The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature. Martora F; Battista T; Ruggiero A; Scalvenzi M; Villani A; Megna M; Potestio L Viruses; 2023 Jun; 15(7):. PubMed ID: 37515110 [No Abstract] [Full Text] [Related]
9. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination. Drago F; Broccolo F; Ciccarese G Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476 [TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations of COVID-19 and COVID-19 vaccination. Nakashima C; Kato M; Otsuka A J Dermatol; 2023 Mar; 50(3):280-289. PubMed ID: 36636825 [TBL] [Abstract][Full Text] [Related]
12. A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran. Soltani S; Matin BK; Gouya MM; Zahraei SM; Moradi G; Chehri O; Soofi M; Moradinazar M; Shadmani FK; Kalantari M; Khajeha H; Emamian MH; Najafi F BMC Public Health; 2023 Jul; 23(1):1415. PubMed ID: 37488541 [TBL] [Abstract][Full Text] [Related]
13. New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review. Wu PC; Huang IH; Wang CW; Tsai CC; Chung WH; Chen CB Am J Clin Dermatol; 2022 Nov; 23(6):775-799. PubMed ID: 36048409 [TBL] [Abstract][Full Text] [Related]
14. Lichen planus and lichen planopilaris flare after COVID-19 vaccination. Diab R; Araghi F; Gheisari M; Kani ZA; Moravvej H Dermatol Ther; 2022 Mar; 35(3):e15283. PubMed ID: 34953018 [TBL] [Abstract][Full Text] [Related]
15. Herpes zoster following vaccination with ChAdOx1 nCoV-19 Coronavirus vaccine (recombinant). Job AM; Sudhamani B; Mohan M; Mohanasundaram SN Indian J Public Health; 2022; 66(1):83-85. PubMed ID: 35381724 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous adverse events related to COVID-19 vaccines: A cross-sectional questionnaire-based study of 867 patients. Pourani MR; Shahidi Dadras M; Salari M; Diab R; Namazi N; Abdollahimajd F Dermatol Ther; 2022 Feb; 35(2):e15223. PubMed ID: 34820975 [TBL] [Abstract][Full Text] [Related]
17. Autoimmune skin disorders and SARS-CoV-2 vaccination - a meta-analysis. Hinterseher J; Hertl M; Didona D J Dtsch Dermatol Ges; 2023 Aug; 21(8):853-861. PubMed ID: 37218538 [TBL] [Abstract][Full Text] [Related]
18. Skin manifestations following anti-COVID-19 vaccination: A multicentricstudy from Turkey. Oguz Topal I; Tokmak A; Kurmuş GI; Kalkan G; Demirseren DD; Tosun M; Emre S; Özkök Akbulut T; Kaya Özden H; Koska MC; Külcü Çakmak S; Kutlu Ö; Mutlu E; Gür Aksoy G; Topaloğlu Demir F; Karadağ AS J Cosmet Dermatol; 2023 Feb; 22(2):354-363. PubMed ID: 36575896 [TBL] [Abstract][Full Text] [Related]
19. A prospective multicenter study on cutaneous reactions reported after Sinopharm COVID-19 vaccination. Shawky A; Elrewiny EM; Gharib K; Sallam M; Mansour M; Rageh MA Int J Dermatol; 2023 Feb; 62(2):221-224. PubMed ID: 35959522 [TBL] [Abstract][Full Text] [Related]
20. Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis. Washrawirul C; Triwatcharikorn J; Phannajit J; Ullman M; Susantitaphong P; Rerknimitr P J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):1947-1968. PubMed ID: 35666609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]